Welcome to our dedicated page for GCM Grosvenor news (Ticker: $GCMG), a resource for investors and traders seeking the latest updates and insights on GCM Grosvenor stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect GCM Grosvenor's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of GCM Grosvenor's position in the market.
GCM Grosvenor (Nasdaq: GCMG), a global alternative asset management solutions provider, announced that Jon Levin, President of GCM Grosvenor, will present at the Morgan Stanley U.S. Financials and Payments Conference on June 12, 2024, at 1:45 PM EDT.
The presentation will be accessible via a live audio webcast on the company's public shareholders website and the event website. A replay will be available for 90 days post-event.
GCM Grosvenor (Nasdaq: GCMG), a global alternative asset management solutions provider, announced that its CEO, Michael Sacks, will present at the TD Financial Services & Fintech Summit on June 7, 2024, at 10:20am EDT.
The presentation will be available via a live audio webcast accessible on GCM Grosvenor's and the event's websites, with a replay available for 90 days post-event.
GCM Grosvenor, a global provider of alternative asset management solutions, announced that its Chairman and CEO, Michael Sacks, will present at the William Blair 44th Annual Growth Stock Conference. The presentation is scheduled for June 5, 2024, at 2:40 p.m. CST. A live audio webcast will be available on the company's public shareholders website and the event website, with a replay accessible for 90 days.
Invidia Capital Management, a new healthcare investment firm founded by former Goldman Sachs partner Jo Natauri, has launched with a strategic investment from GCM Grosvenor. Natauri, who brings over 25 years of experience, has assembled a team of senior advisors and experienced professionals from top firms like Goldman Sachs, TPG, and KKR. Invidia aims to focus on upper-middle market investment opportunities in the $4.5 trillion healthcare sector, targeting cost containment, quality, access, and innovation for long-term growth. GCM Grosvenor, which manages about $79 billion in assets, expressed confidence in Invidia's potential to become a leading force in healthcare innovation.
GCM Grosvenor (Nasdaq: GCMG) released its first quarter 2024 earnings results, available on their website. A conference call to discuss the financial results was scheduled for May 7, 2024.